Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 213 | 291 | 272 | 421 | 426 |
| Operating Income | -213 | -291 | -260 | -421 | -438 |
| Interest Expense | 119 | 86 | 90 | 133 | 265 |
| Other Income | -98 | 23 | -9 | 27 | -10 |
| Pre-tax Income | -430 | -354 | -359 | -527 | -713 |
| Income Tax | N/A | N/A | -1 | 0 | -129 |
| Net Income Continuous | -430 | -354 | -358 | -527 | -584 |
| Net Income | $-430 | $-354 | $-359 | $-527 | $-584 |
| EPS Basic Total Ops | -805.75 | -899.25 | 17,120.29 | -13,644.75 | -38,988.75 |
| EPS Basic Continuous Ops | -805.77 | -899.36 | 17,941.44 | -13,260.81 | -36,800.00 |
| EPS Diluted Total Ops | -805.75 | -899.25 | 17,120.29 | -13,644.75 | -38,988.75 |
| EPS Diluted Continuous Ops | -805.77 | -899.36 | 17,941.44 | -13,260.81 | -36,800.00 |
| EPS Diluted Before Non-Recurring Items | -805.75 | 0.00 | N/A | N/A | N/A |
| EBITDA(a) | $-213 | $-291 | $-272 | $-421 | $-426 |